ArticleBritish journal of cancer2012

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours.

S Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.